Cargando…
Possible therapeutic effect of orally administered ribavirin for respiratory syncytial virus-induced acute respiratory distress syndrome in an immunocompetent patient: a case report
BACKGROUND: Human respiratory syncytial virus usually causes self-limiting upper respiratory infection and occasionally causes pneumonia in immunocompromised hosts. Respiratory syncytial virus-induced severe pneumonia or acute respiratory distress syndrome in immunocompetent adults has been rarely d...
Autores principales: | Yoon, Byung Woo, Lee, Seung Hyeun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738173/ https://www.ncbi.nlm.nih.gov/pubmed/29258592 http://dx.doi.org/10.1186/s13256-017-1514-x |
Ejemplares similares
-
RIBAVIRIN AND RESPIRATORY SYNCYTIAL VIRUS
Publicado: (1986) -
1600. An Optimal Respiratory Syncytial Virus (RSV) Treatment in Lung Transplant Recipients: Oral Ribavirin, Inhaled Ribavirin, or Conservative Approach
por: Permpalung, Nitipong, et al.
Publicado: (2018) -
Respiratory Syncytial Virus Infection Morbidity in the Elderly: Time for Repurposing of Ribavirin?
por: de Zwart, Auke E S, et al.
Publicado: (2020) -
Successful Treatment of Respiratory Syncytial Virus Infection in an Immunocompromised Patient With Ribavirin
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021) -
Transient Neutropenia in Immunocompetent Infants with Respiratory Syncytial Virus Infection
por: Korematsu, Tatsuya, et al.
Publicado: (2021)